SCHEMBL21439934

SCHEMBL21439934

Cc1ccc(/C=C/c2cccc(-c3cccc4c3Sc3ccccc3S4)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 6/20 0.44
ALOX5 P09917 2/20 0.40
KDM1A O60341 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
RELA Q04206 1/20 0.36
HPGD P15428 3/20 0.36
KDM4E B2RXH2 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
NR1H3 Q13133 1/20 0.35
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
CASP3 P42574 2/20 0.33
SENP8 Q96LD8 2/20 0.33
SENP7 Q9BQF6 2/20 0.33
SENP6 Q9GZR1 2/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16174593 0.90 ALOX5 (0.43) NFE2L2ALOX5KDM1AHDAC1HDAC6
SCHEMBL3287495 0.79 ALOX5 (0.49) ALOX5HDAC6RELAHPGDSMN1; SMN2
SCHEMBL23555385 0.79 ALOX5 (0.47) ALOX5HDAC6HPGDKDM4ESMN1; SMN2
SCHEMBL16174592 0.79 ALOX5 (0.45) ALOX5HDAC6
SCHEMBL23555387 0.78 ALOX5 (0.46) ALOX5HDAC6HPGDKDM4ESMN1; SMN2
SCHEMBL14802125 0.74 ALOX5 (0.40) ALOX5HPGDKDM4ESMN1; SMN2NPC1
SCHEMBL22173936 0.73 KDM1A (0.31) ALOX5KDM1AHDAC1HDAC6
SCHEMBL10985315 0.72 ALOX5 (0.53) ALOX5HDAC6HPGDPTGS2
SCHEMBL17474342 0.72 ALOX5 (0.58) ALOX5HDAC6HPGDKDM4EPTGS1
SCHEMBL16166718 0.71 ALOX5 (0.41) ALOX5HDAC6HPGDKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439147-B2 Heterocyclic compounds and their use in electro-optical or opto-electronic devices POWER OLEDS LIMITED (GB) 2019-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439147-B2 Heterocyclic compounds and their use in electro-optical or opto-electronic devices NAT1, SLCO2A1, SLCO2B1 NFE2L2 564/4885ALOX5 445/4885KDM1A 2761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.